https://insights.citeline.comTue, 12 Nov 2024 09:41:01 +0000en1hourly1https://insights.citeline.com/scrip/r-and-d/clinical-trials/value-of-abbvies-cerevel-buy-uncertain-after-schizophrenia-failure-H4DMM5A3INHV3IXLCN64CAMR3E/https://insights.citeline.com/scrip/r-and-d/clinical-trials/value-of-abbvies-cerevel-buy-uncertain-after-schizophrenia-failure-H4DMM5A3INHV3IXLCN64CAMR3E/Mon, 11 Nov 2024 22:50:29 +0000https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-sanofiregenerons-dupixent-gets-eu-eosinophilic-esophagitis-approved-for-young-children-VHKLSHWLKVGSXND26LSLTFDI2U/https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-sanofiregenerons-dupixent-gets-eu-eosinophilic-esophagitis-approved-for-young-children-VHKLSHWLKVGSXND26LSLTFDI2U/Mon, 11 Nov 2024 15:05:01 +0000https://insights.citeline.com/scrip/therapeutic-category/immunological/rapt-scraps-zelnecirnon-but-not-giving-up-on-ccr4-RZ22FTLM4RGTVBY6BVWTWIMX5U/https://insights.citeline.com/scrip/therapeutic-category/immunological/rapt-scraps-zelnecirnon-but-not-giving-up-on-ccr4-RZ22FTLM4RGTVBY6BVWTWIMX5U/Mon, 11 Nov 2024 20:38:37 +0000